Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
GMED's Cash to Debt is ranked higher than
88% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: 1.18 vs. GMED: No Debt )
Ranked among companies with meaningful Cash to Debt only.
GMED' s 10-Year Cash to Debt Range
Min: N/A   Max: No Debt
Current: No Debt


Warning: Division by zero in /home/gurufocu/public_html/include/common_stock_functions_2.php on line 6421
N/A
No Debt
Equity to Asset 0.83
GMED's Equity to Asset is ranked higher than
85% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: 0.52 vs. GMED: 0.83 )
Ranked among companies with meaningful Equity to Asset only.
GMED' s 10-Year Equity to Asset Range
Min: 0.83   Max: 0.88
Current: 0.83

0.83
0.88
Interest Coverage No Debt
GMED's Interest Coverage is ranked higher than
90% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GMED: No Debt )
Ranked among companies with meaningful Interest Coverage only.
GMED' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 4
Z-Score: 13.88
M-Score: -1.75
WACC vs ROIC
2.42%
32.37%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 29.41
GMED's Operating margin (%) is ranked higher than
97% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: -10.56 vs. GMED: 29.41 )
Ranked among companies with meaningful Operating margin (%) only.
GMED' s 10-Year Operating margin (%) Range
Min: 23.4   Max: 30.43
Current: 29.41

23.4
30.43
Net-margin (%) 19.52
GMED's Net-margin (%) is ranked higher than
94% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: -12.96 vs. GMED: 19.52 )
Ranked among companies with meaningful Net-margin (%) only.
GMED' s 10-Year Net-margin (%) Range
Min: 15.79   Max: 19.5
Current: 19.52

15.79
19.5
ROE (%) 17.24
GMED's ROE (%) is ranked higher than
90% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: -14.48 vs. GMED: 17.24 )
Ranked among companies with meaningful ROE (%) only.
GMED' s 10-Year ROE (%) Range
Min: 15.98   Max: 43.04
Current: 17.24

15.98
43.04
ROA (%) 14.49
GMED's ROA (%) is ranked higher than
95% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: -7.12 vs. GMED: 14.49 )
Ranked among companies with meaningful ROA (%) only.
GMED' s 10-Year ROA (%) Range
Min: 13.54   Max: 36.91
Current: 14.49

13.54
36.91
ROC (Joel Greenblatt) (%) 72.22
GMED's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: -26.51 vs. GMED: 72.22 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
GMED' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 59.22   Max: 139.86
Current: 72.22

59.22
139.86
» GMED's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

GMED Guru Trades in Q2 2014

Paul Tudor Jones 28,222 sh (New)
Joel Greenblatt 920,280 sh (+755.92%)
Jim Simons 786,400 sh (+334.20%)
Steven Cohen 351,000 sh (unchged)
RS Investment Management Sold Out
Ronald Muhlenkamp Sold Out
» More
Q3 2014

GMED Guru Trades in Q3 2014

Paul Tudor Jones 52,495 sh (+86.01%)
Joel Greenblatt 1,165,867 sh (+26.69%)
Jim Simons 852,500 sh (+8.41%)
Steven Cohen Sold Out
» More
Q4 2014

GMED Guru Trades in Q4 2014

Steven Cohen 789,800 sh (New)
Paul Tudor Jones 44,990 sh (-14.30%)
Joel Greenblatt 571,767 sh (-50.96%)
Jim Simons 250,100 sh (-70.66%)
» More
Q1 2015

GMED Guru Trades in Q1 2015

Louis Moore Bacon 100,000 sh (New)
Steven Cohen 523,600 sh (-33.70%)
Joel Greenblatt 245,402 sh (-57.08%)
Paul Tudor Jones 19,032 sh (-57.70%)
Jim Simons 98,300 sh (-60.70%)
» More
» Details

Insider Trades

Latest Guru Trades with GMED

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 25.60
GMED's P/E(ttm) is ranked higher than
82% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GMED: 25.60 )
Ranked among companies with meaningful P/E(ttm) only.
GMED' s 10-Year P/E(ttm) Range
Min: 12.95   Max: 35.54
Current: 25.6

12.95
35.54
Forward P/E 22.32
GMED's Forward P/E is ranked higher than
76% of the 378 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GMED: 22.32 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 25.30
GMED's PE(NRI) is ranked higher than
84% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GMED: 25.30 )
Ranked among companies with meaningful PE(NRI) only.
GMED' s 10-Year PE(NRI) Range
Min: 12.96   Max: 35.64
Current: 25.3

12.96
35.64
P/B 3.80
GMED's P/B is ranked lower than
61% of the 368 Companies
in the Global Medical Devices industry.

( Industry Median: 3.30 vs. GMED: 3.80 )
Ranked among companies with meaningful P/B only.
GMED' s 10-Year P/B Range
Min: 2.45   Max: 4.94
Current: 3.8

2.45
4.94
P/S 4.90
GMED's P/S is ranked lower than
80% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GMED: 4.90 )
Ranked among companies with meaningful P/S only.
GMED' s 10-Year P/S Range
Min: 2.48   Max: 5.61
Current: 4.9

2.48
5.61
PFCF 41.40
GMED's PFCF is ranked higher than
71% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GMED: 41.40 )
Ranked among companies with meaningful PFCF only.
GMED' s 10-Year PFCF Range
Min: 18.52   Max: 43
Current: 41.4

18.52
43
POCF 28.99
GMED's POCF is ranked higher than
73% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GMED: 28.99 )
Ranked among companies with meaningful POCF only.
GMED' s 10-Year POCF Range
Min: 12.65   Max: 30.05
Current: 28.99

12.65
30.05
EV-to-EBIT 15.26
GMED's EV-to-EBIT is ranked higher than
88% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GMED: 15.26 )
Ranked among companies with meaningful EV-to-EBIT only.
GMED' s 10-Year EV-to-EBIT Range
Min: 6.7   Max: 21.3
Current: 15.26

6.7
21.3
Current Ratio 4.88
GMED's Current Ratio is ranked higher than
80% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: 2.04 vs. GMED: 4.88 )
Ranked among companies with meaningful Current Ratio only.
GMED' s 10-Year Current Ratio Range
Min: 4.88   Max: 10.12
Current: 4.88

4.88
10.12
Quick Ratio 3.82
GMED's Quick Ratio is ranked higher than
76% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: 1.53 vs. GMED: 3.82 )
Ranked among companies with meaningful Quick Ratio only.
GMED' s 10-Year Quick Ratio Range
Min: 3.82   Max: 8.29
Current: 3.82

3.82
8.29
Days Inventory 258.24
GMED's Days Inventory is ranked lower than
57% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 198.08 vs. GMED: 258.24 )
Ranked among companies with meaningful Days Inventory only.
GMED' s 10-Year Days Inventory Range
Min: 125.66   Max: 266.18
Current: 258.24

125.66
266.18
Days Sales Outstanding 54.31
GMED's Days Sales Outstanding is ranked higher than
80% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 96.55 vs. GMED: 54.31 )
Ranked among companies with meaningful Days Sales Outstanding only.
GMED' s 10-Year Days Sales Outstanding Range
Min: 50.59   Max: 58.04
Current: 54.31

50.59
58.04

Valuation & Return

vs
industry
vs
history
Price/Net Cash 29.30
GMED's Price/Net Cash is ranked higher than
75% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GMED: 29.30 )
Ranked among companies with meaningful Price/Net Cash only.
GMED' s 10-Year Price/Net Cash Range
Min: 6.32   Max: 28.68
Current: 29.3

6.32
28.68
Price/Net Current Asset Value 13.00
GMED's Price/Net Current Asset Value is ranked higher than
70% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GMED: 13.00 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
GMED' s 10-Year Price/Net Current Asset Value Range
Min: 3.2   Max: 7.36
Current: 13

3.2
7.36
Price/Tangible Book 5.00
GMED's Price/Tangible Book is ranked higher than
54% of the 379 Companies
in the Global Medical Devices industry.

( Industry Median: 5.30 vs. GMED: 5.00 )
Ranked among companies with meaningful Price/Tangible Book only.
GMED' s 10-Year Price/Tangible Book Range
Min: 2.65   Max: 5.51
Current: 5

2.65
5.51
Price/Median PS Value 1.20
GMED's Price/Median PS Value is ranked higher than
50% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GMED: 1.20 )
Ranked among companies with meaningful Price/Median PS Value only.
GMED' s 10-Year Price/Median PS Value Range
Min: 0.6   Max: 1.36
Current: 1.2

0.6
1.36
Price/Graham Number 2.40
GMED's Price/Graham Number is ranked higher than
79% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. GMED: 2.40 )
Ranked among companies with meaningful Price/Graham Number only.
GMED' s 10-Year Price/Graham Number Range
Min: 1.24   Max: 2.96
Current: 2.4

1.24
2.96
Earnings Yield (Greenblatt) 6.70
GMED's Earnings Yield (Greenblatt) is ranked higher than
88% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: -2.60 vs. GMED: 6.70 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
GMED' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.7   Max: 15
Current: 6.7

4.7
15

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:GM0N.Germany,
Globus Medical Inc was incorporated in Delaware in March 3, 2003. The Company is a medical device company focused exclusively on the design, development and commercialization of musculoskeletal implants. It is currently focused on implants that promote healing in patients with spine disorders. All of its products fall into one of two categories: Innovative Fusion or Disruptive Technologies. The Company's Innovative Fusion products address a spinal fusion surgical procedures. Spinal fusion is a surgical procedure to correct problems with the individual vertebrae, the interlocking bones making up the spine, by preventing movement of the affected bones. It currently offers over 120 products for the treatment of spine disorders. Products in Innovative Fusion includes: CREO, a convenient non-threaded locking cap design that eases building of thoracolumbar fixation constructs to readily adapt to the patient's anatomy and condition, for a range of clinical applications. XPAND, FORTIFY, FORTIFY-I corpectomy devices that incorporate smooth expansion capability, have a range of size options for optimal fit, and are manufactured from titanium or radiolucent polyetheretherketone. COALITION and INDEPENDENCE stand-alone interbody fusion devices, simplify the surgical technique by reducing steps and hardware while providing confident stabilization. Disruptive Technologies represent a shift in the treatment of spine disorders by allowing for novel surgical procedures, improvements to existing surgical procedures, and the treatment of spine disorders by new physician specialties, and surgical intervention earlier in the continuum of care. Products in Disruptive Technologies includes: MIS products which enable a surgeon to perform a procedure less invasively to minimize tissue disruption and maximize native anatomy, for patient recovery and fewer approach-related complications. For example, MARS 3V retractor system facilitates smaller incisions with the use of positionable radiolucent retractor blades to access the surgical site and to allow both direct and radiographic visualization. CALIBER, RISE and recently launched LATIS expandable interbody spacers are designed for reliable, minimally disruptive delivery through small MIS incisions with streamlined implants and instruments. REVOLVE pedicle screw system is designed for MIS screw and rod insertion through small incisions, and utilizes a convenient non-threaded locking cap design. TRANSITION, provide for stabilization that is less rigid than traditional pedicle screw systems for more natural load distribution to help promote fusion while maintaining stability. Other products included are SECURE-C, SECURE-CR, KINEX, MICROFUSE, SHIELD, AFFIRM, among others. Company's competitors include: Medtronic, the DePuy Synthes Companies, Stryker and NuVasive. Alphatec Spine, Orthofix International, Zimmer, LDR, among others. As of December 31, 2013, the Company owned 188 issued U.S. patents and had applicat
» More Articles for GMED

Headlines

Articles On GuruFocus.com
Weekly CEO Sells Highlight: Globus Medical Inc, Diplomat Pharmacy Inc, Zendesk Inc, and Amicus Thera Mar 28 2015 

More From Other Websites
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of... May 28 2015
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Civil Securities Claims Against Globus... May 20 2015
Looking for a Top Growth Stock? 3 Reasons Why Globus Medical (GMED) Is an Impressive Choice - Tale... May 18 2015
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of... May 14 2015
GLOBUS MEDICAL INC Financials May 13 2015
Globus Medical beats Street 1Q forecasts May 05 2015
Globus Medical beats Street 1Q forecasts May 05 2015
Globus Medical Reports First Quarter 2015 Results May 05 2015
Globus Medical Inc Earnings Call scheduled for 5:30 pm ET today May 05 2015
GLOBUS MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition May 05 2015
Globus Medical Reports First Quarter 2015 Results May 05 2015
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of... May 05 2015
Q1 2015 Globus Medical Inc Earnings Release - After Market Close May 05 2015
Globus Medical, Inc. Investors Encouraged to Contact Securities Law Firm about Investigation into... Apr 30 2015
GMED INVESTOR ALERT: Globus Medical, Inc. Shareholders Encouraged to Contact The Wagner Firm... Apr 28 2015
Harwood Feffer LLP Announces Investigation of Globus Medical, Inc. Apr 27 2015
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Globus Medical, Inc.... Apr 24 2015
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical,... Apr 24 2015
GMED INVESTOR ALERT: Investigation of Globus Medical, Inc. Announced by The Law Offices of Howard G.... Apr 24 2015
GLOBUS MEDICAL INC Files SEC form 8-K, Financial Statements and Exhibits Apr 24 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK